Halstead Michael purchased $1.3M of HELP
Halstead Michael (Chief Executive Officer) purchased 100,000 shares of CYBIN INC. (HELP) at $13.47 ($1.35M total) on 2026-09-21.
How this was made
The 30-second read
Why it matters
The purchase adds to CEO's ownership, possibly indicating confidence in upcoming developments.
Market read
Insider purchase may modestly influence HELP's stock price; relevance limited to traders tracking insider activity.
What to watch
Potential upcoming clinical trial data or regulatory news not disclosed.
Background
Form 4 filing reports insider transactions; such filings are primary sources for insider activity.
Ticker impact
CEO Halstead Michael bought 100,000 shares of Cybin Inc. for $1.35M, increasing his stake to 168,568 shares.
Potential slight upward pressure in near term.
CEO acquisition of $1.3M worth of stock is a primary disclosure but modest in scale; traders may view as a mild bullish cue.
Market effects
Limited impact on biotech sector; reflects insider confidence.
Minimal regional effect.
Low global relevance.
Counterpoint
Insider buying could be routine portfolio rebalancing, not a strong signal.
Key entities
- CompanyCybin Inc.
Biopharmaceutical company developing psychedelic therapeutics.
- IndividualHalstead Michael
Chief Executive Officer of Cybin Inc.